Longeveron (LGVN) Profit After Tax (2020 - 2026)

Longeveron's (LGVN) quarterly Profit After Tax came in at -$4.7 million in Q1 2026, up 5.49% year-on-year from -$4.5 million in Q1 2025, and up 12.36% quarter-over-quarter from -$5.4 million in Q4 2025.

Longeveron (LGVN) Profit After Tax (2020 - 2026) Analysis & Trends

Longeveron's Profit After Tax history runs 7 years deep, the most recent figure standing at -$4.7 million for Q1 2026.

  • On a quarterly basis, Profit After Tax rose 5.49% year-over-year to -$4.7 million in Q1 2026; TTM through Mar 2026 was -$22.4 million, a 32.35% decrease from a year earlier, with the FY2025 full-year figure at -$22.7 million, down 42.14% from the prior year.
  • Profit After Tax improved to -$4.7 million in Q1 2026 per LGVN's latest filing, from -$5.4 million in the prior quarter.
  • Across five years, Profit After Tax topped out at -$3.4 million in Q2 2024 and bottomed at -$7.2 million in Q3 2025.
  • The 5-year median for Profit After Tax is -$5.0 million (2025), against an average of -$4.9 million.
  • Across the five-year window, Profit After Tax surged 39.4% in 2024 and tumbled 63.41% in 2025, its largest moves.
  • Year by year, Profit After Tax stood at -$4.5 million in 2022, then sank by 35.25% to -$6.0 million in 2023, then soared by 32.43% to -$4.1 million in 2024, then slumped by 32.68% to -$5.4 million in 2025, then increased by 12.36% to -$4.7 million in 2026.
  • Per Business Quant, the three latest LGVN Profit After Tax figures stand at -$4.7 million (Q1 2026), -$5.4 million (Q4 2025), and -$7.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn - -36.84 Mn
2 Nanobiotix 1,908.96 Bn 1,908.90 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -14.46 Mn
4 BeOne Medicines 474.03 Bn 469.24 Bn 1.35 Bn 227.36 Mn
5 Vertex Pharmaceuticals 122.13 Bn 114.88 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 70.09 Bn 61.34 Bn 3.31 Bn -65.60 Mn
7 Belite Bio 62.34 Bn 62.34 Bn - -26.94 Mn
8 Argenx Se 55.96 Bn 50.77 Bn 1.41 Bn 362.00 Mn
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn 205.99 Mn
10 Longeveron 15.36 Bn 15.34 Bn 264,000.00 -4.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.74 Mn
Dec 31, 2025 -5.40 Mn
Sep 30, 2025 -7.22 Mn
Jun 30, 2025 -5.03 Mn
Mar 31, 2025 -5.01 Mn
Dec 31, 2024 -4.07 Mn
Sep 30, 2024 -4.42 Mn
Jun 30, 2024 -3.41 Mn
Mar 31, 2024 -4.10 Mn
Dec 31, 2023 -6.03 Mn
Sep 30, 2023 -5.11 Mn
Jun 30, 2023 -5.63 Mn
Mar 31, 2023 -4.60 Mn
Dec 31, 2022 -4.46 Mn
Sep 30, 2022 -5.24 Mn
Jun 30, 2022 -5.62 Mn
Mar 31, 2022 -3.51 Mn
Dec 31, 2021 -4.07 Mn
Sep 30, 2021 -4.86 Mn
Jun 30, 2021 -5.01 Mn